The smoking cessation efficacy of bupropion hydrochloride sustained release tablets (BUP SR) versus placebo (PBO) in smokers with chronic obstructive pulmonary disease (COPD) with respect to age, gender, pack-year history and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 192s Year: 2001
Effectiveness of N-acetyl cyctein (NAC) to reduce cough when used together with other over-the-counter (OTC) in common cold (a preliminary study) Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
Enhanced training on how to use a dry powder inhaler (DPI) improves the inhalation manoeuvre (IM) of patients with asthma (child 6–17 yrs and adult >17 yrs) or COPD and in healthy adults (HA) when they use a Spiromax® (S) and Turbuhaler® (T) DPI Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013
Changes in the use of anti-asthmatic medication in an international cohort Source: Eur Respir J 2005; 26: 1047-1055 Year: 2005
Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study Source: Eur Respir J 2009; 33: 1010-1017 Year: 2009
Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010
Prescribed doses and effect on asthma treatment outcomes of extrafine (ciclesonide) vs standard particle inhaled corticosteroids (ICS) Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015
Anti-inflammatory effect of montelukast (ML) and inhaled steroids (ICS) on clinical parameters and serum levels of NO in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 132s Year: 2003
Tobacco smoke and inhaled medications interactions (TIMED) study: asthma and COPD smokers’ habits about inhalers and cigarettes. Preliminary results Source: Annual Congress 2004 - Update on smoking related damage and cessation Year: 2004
Effect of codeine (30mg) with paracetamol (650mg) on post bronchoscopy coughing –an open labeled placebo control trial Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease Year: 2019
EABPCP-CPHG study: characteristics of COPD women hospitalised for acute exacerbation (ae) according to their tobacco consumption Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009
Reduced maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children Source: Annual Congress 2006 - Childhood asthma in Europe - is it still increasing and what are the causes? Year: 2006
High doses of omalizumab (OMA) in patients with allergic (IgE-mediated) asthma and IgE/body weight combinations outside the initially approved dosing table Source: Annual Congress 2010 - Treatment options for asthma Year: 2010
Safety and pharmacokinetics of two dose strengths of ciprofloxacin dry powder for inhalation (DPI) in patients with moderate to severe COPD Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012
Over-the-counter (OTC) ß2-agonist purchase is not associated with poor asthma control: a random, community study Source: Eur Respir J 2006; 28: Suppl. 50, 685s Year: 2006
Ease of use of a two-strip dry powder inhaler (DPI) to deliver fluticasone furoate/vilanterol (FF/VI) and FF alone in asthma Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013
Inhalation characteristics with Spiromax® (S) versus Turbuhaler® (T) dry powder inhalers (DPI) in healthy adults (HA) and in patients with asthma (A) or COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
Paracetamol use in relation to asthma, hayfever, eczema and their current symptoms Source: Eur Respir J 2003; 22: Suppl. 45, 313s Year: 2003
A natural experiment on the impact of fruit supplementation on asthma symptoms in children Source: Eur Respir J 2009; 33: 481-485 Year: 2009
Comparison of ciclesonide once daily (80 μg/d, 160 μg/d) and fluticasone propionate twice daily (176 μg/d) in the treatment of children with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 457s Year: 2007